Biomimesys
HCS Pharma in Taïwan beside our partner Molecular Devices
Nathalie Maubon CEO of HCS Pharma will be alongside with our longtime partner Molecular Devices in Taiwan on the 5th of October. This event as always is designed by Molecular Devices to inspire, educate, and connect scientists, researchers, and professionals Read more…
Biomimesys
HCS Pharma at 8th Bioproduction congress in Lyon on october 4-6 2023
In HCS Pharma we strongly believe that 3D cell culture is the right way to improve drug dicovery processes. Moreover, we know that our 3D HydroscaffoldTM matrix BIOMIMESYS® could be useful for bioproduction. We will be happy to meet you at “8th Read more…
Biomimesys
Feedback of Rania’s internship about the development of primary human hepatocyte model in biochip microfludic system
This is the end of Rania‘s 6-month internship in HCS Pharma about a new liver biochip system. After a first publication “Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver’s Extracellular Matrix” in collaboration with the University of Technology of Read more…
News
Join us in Paris at Cosmetic 360, October 18 and 19
The great meeting for the cosmetic field “Cosmetic 360” is back again ! Oceane GUYOT our project manager in dermocosmetology and Rita HIEN our business developper will be at this event on the 18th/19th and are looking forward to see Read more…
News
Nathalie Maubon in China on the 27th of September for the life science summit
HCS Pharma is speeding up its expansion into Asia ! Our CEO/CSO Mme. Nathalie MAUBON will again be in Asia and speak for the first time in China ! Mme. MAUBON will deliver a speech at Shanghai Zhangjiang Life Science Read more…
News
HCS Pharma @ELRIG congress in Basel “Advancements in cell & gene therapy: new therapeutic horizons” on Friday, 15th september 2023
In HCS Pharma we strongly believe that 3D cell culture is the right way to improve drug dicovery processes. Moreover, we know that our 3D hydroscaffold matrix BIOMIMESYS® could be useful for bioproduction and then for cell therapy. We will be happy Read more…
Biomimesys
New article about BIOMIMESYS® in different research fields
Find out more about BIOMIMESYS® and its wide range of applications (oncology, neurosciences, metabolism, adipocyte research) in this informative article. A comprehensive article describing the benefits of our products and the importance of results in research projects. For any question Read more…
News
Novelty on the redness assessment!
Skin redness is a sign of cutaneous inflammation which can lead to major skin disorders. When the skin is exposed to allergens, irritants, pathogens, or UV rays, cells produce a variety of inflammatory cytokines which bind to specific receptors on target cells. This Read more…
News
Welcome back to work !
Positive thinking = positive living ! Welcome back to work ! HCS Pharma wishes you a safe return to work and stay available to advice you about how our breaktrough 3D technologies BIOMIMESYS® declined for multiple specific research field can Read more…
Biomimesys
Thomas Meynard won the prize for the best poster at the FEBS Congress by presenting his work on BIOMIMESYS®-on-chips
Thomas Meynard is a PhD student in OncoLille Laboratory (Canther Lab, Mucine Team), under the supervision of Dr. Isabelle Van Seuningen and Dr. Vincent Senez. His PhD work is focused on the development of microfluidic systems to study Pancreatic Ductal Read more…
Biomimesys
New press release out: HCS Pharma, LumiSTAR Biotech & MolDev explore stem cell-derived organoids for drug screening
In Asia for a business trip, Nathalie Maubon, PhD, CEO & CSO of HCS Pharma, participated in a symposium during BioAsia event on late July, together with LumiSTAR Biotechnology (Taïwan) and Molecular Devices (USA). On this occasion, the 3 companies Read more…
Biomimesys
Full of stars in BIOMIMESYS !
The Perseid meteor shower which is taking place on the 14th of July and will finish on the 1st September will reach its high point between the 10 and the 14th of August. Debris from comet Swift-Tuttle, which has broken Read more…
Biomimesys
HCS Pharma is delighted to help Vidac Pharma in the fight against cancer
Rehovot (Israel) London (UK) and Lille (France) Vidac Pharma is a clinical stage biopharmaceutical company dedicated to discovering and developing First-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. Vidac Pharma and HCS Pharma announce Read more…
News
HCS Pharma @BioAsia Taiwan 2023
We are happy to share that Nathalie Maubon, PhD, our CEO/CSO is currently attending BioAsia Taiwan, organized in Taipei. The event aims at building on the success of recent years’ gatherings to bring together biotechnology and pharmaceutical executives and investors Read more…
Biomimesys
Adipose tissue, the core of fat accumulation
Organisms store lipids when they consume more energy than they can use immediately. In mammals, adipose tissue, in addition to its role as an endocrine organ, is specialized in fat storage. Adipose tissue is mainly composed of adipocytes. Until recently, Read more…
Biomimesys
Collaboration with CANTHER about breast cancer metastasis presented @EACR2023
Julien Cicero, with whom we are collaborating about the study of breast cancer metastasis mechanisms, was proud to present his PhD work during the last EACR conference. It was held in Torino (Italy) last month, during which Julien could discuss Read more…
News
Avancées prometteuses dans la lutte contre le cancer : les projets innovants de HCS Pharma
Chez HCS Pharma, nous sommes ravis de partager avec vous les avancées significatives que nous avons réalisées dans nos projets de recherche et développement. Avant de commencer, nous tenons à remercier “La Gazette du Laboratoire” pour leur soutien continu et Read more…
Biomimesys
HCS Pharma in BioAsia-Taiwan Focus Symposium in Drug Discovery
We are really pleased to announce that we will be present in BioAsia-Taiwan and present our breakthrough technology BIOMIMESYS alongside our partners Molecular Devices (USA) and LumiSTAR Biotechnology (TW). We are 3 companies in 3 different continents unifying their strenghs Read more…
Biomimesys
New test available : Slimming assessment !
Our BIOMIMESYS® Adipose tissue extracellular matrix expands our 3D study possibilities ! HCS Pharma offers you a new 3D test for the evaluation of slimming properties of your actives ingredients. It offers you the possibility to observe the fat-inhibiting potential Read more…
News
Business trip in Asia: what makes China different !
After Japan, the business trip has been been continued in Taïwan for several days! As a scientist, I was really happy to see such open-mind spirit when I present BIOMIMESYS technology and how this kind of technology will change the Read more…
Subscribe to our Newsletter
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.